News Conference News EuroPCR 2024 ORBITA-2: Angina Phenotype Strongly Predicts PCI Response Caitlin E. Cox May 15, 2024
News Conference News EuroPCR 2021 FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold Michael O'Riordan May 19, 2021
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2019 EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal L.A. McKeown May 23, 2019
News Conference News EuroPCR 2019 Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers Caitlin E. Cox May 23, 2019
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
News Features EuroPCR 2017 Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles Yael L. Maxwell June 01, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2014 EuroPCR Features PAD Therapies in Early Development and Real-World Use Caitlin E. Cox May 21, 2014
News Conference News EuroPCR 2013 Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices Jason Kahn May 22, 2013